United Kingdom · Question · Written question
UIN 6500
Neuroblastoma: Drugs
Introduced
4 October 2024
Last action
11 October 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
11 October 2024
Summary
To ask the Secretary of State for Health and Social Care, whether he plans to make difluoromethylornithine available on the NHS for children with high-risk neuroblastoma.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
4 October 2024
Written question
To ask the Secretary of State for Health and Social Care, whether he plans to make difluoromethylornithine available on the NHS for children with high-risk neuroblastoma.
Source: Commons
11 October 2024
Answer
We understand how important it is that cancer patients are able to benefit from rapid access to effective new treatments. We are aware that the manufacturer difluoromethylornithine (DFMO) has applied for a United Kingdom marketing authorisation through Pr...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-10-04/6500
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1730648
- uk · wq-1730648 · source updated 11 October 2024